Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000679504 | SCV000529724 | likely benign | not provided | 2020-05-18 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001087575 | SCV000646603 | likely benign | Colorectal cancer, susceptibility to, 10 | 2024-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000571738 | SCV000671156 | likely benign | Hereditary cancer-predisposing syndrome | 2017-07-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000679504 | SCV000806513 | likely benign | not provided | 2017-01-10 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001821194 | SCV002068285 | likely benign | not specified | 2018-01-16 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001821194 | SCV002551976 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000679504 | SCV004183693 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | POLD1: BP4, BP7 |